GlobeNewswire Inc.··NaOculis to Showcase Optic Neuritis Data as Privosegtor Advances to Pivotal Trials
Oculis presents Phase 2 ACUITY trial results for Privosegtor at neuro-ophthalmology conference, showing vision improvements. Breakthrough therapy advances to registrational PIONEER program.
OCSOCSAWPrivosegtoroptic neuritis